Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 95,405 shares at $49.15 ($4.7M) on 2021-07-08, disclosed to the SEC on 2021-07-09.
Open-market sale of $4.7M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.15 | 17,230 | $847K | 17.9% |
| 2 | $49.15 | 17,230 | $847K | 17.9% |
| 3 | $49.71 | 23,803 | $1.2M | 25.0% |
| 4 | $49.71 | 23,803 | $1.2M | 25.0% |
| 5 | $50.96 | 6,372 | $325K | 6.9% |
| 6 | $50.96 | 6,372 |
| $325K |
| 6.9% |
| 7 | $51.64 | 595 | $31K | 0.6% |
| Total | $49.69 avg | 95,405 | $4.7M | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |